Long-term outcome of multimodal therapy for giant prolactinomas-Reference-Cited by-同舟云学术

Long-term outcome of multimodal therapy for giant prolactinomas

Published:2016-10-04 Issue:1 Volume:55 Page:231-238
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Andujar-Plata Paula,Villar-Taibo Rocio,Ballesteros-Pomar Maria Dolores,Vidal-Casariego Alfonso,Pérez-Corral Begoña,Cabezas-Agrícola Jose Manuel,Álvarez-Vázquez Paula,Serramito Ramón,Bernabeu Ignacio

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-016-1129-9.pdf

Reference27 articles.

1. A.B. Moraes, C.M. Dos Santos Silva, L. Vieira Neto, M.R. Gadelha, Giant prolactinomas: the therapeutic approach. Clin. Endocrinol. (Oxf.) 79(4), 447–456 (2013)

2. I. Shimon, C. Benbassat, M. Hadani, Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur. J. Endocrinol. 156(2), 225–231 (2007)

3. D. Maiter, E. Delgrange, Therapy of endocrine disease: the challenges in managing giant prolactinomas. Eur. J. Endocrinol. 170, 13–27 (2014)

4. S. Dash, A.K. Annamalai, H.L. Simpson, N. Sarkies, N.M. Antoun, R. Mannion, Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour. QJM. 106, 85 (2013)

5. R.K. Shrivastava, M.S. Arginteanu, W.A. King, K.D. Post, Giant prolactinomas: clinical management and long-term follow up. J. Neurosurg. 97(2), 299–306 (2002)

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Giant prolactinomas, a detailed analysis of 196 adult cases;Pituitary;2023-08-07

2. Long-term Follow-up of 84 Patients With Giant Prolactinomas—A Swedish Nationwide Study;The Journal of Clinical Endocrinology & Metabolism;2023-07-04

3. Prognostic Models in Growth-Hormone- and Prolactin-Secreting Pituitary Neuroendocrine Tumors: A Systematic Review;Diagnostics;2023-06-19

4. Surgical Management of Giant Prolactinomas: A Descriptive Study;International Journal of Endocrinology;2023-04-25

5. Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?;European Journal of Endocrinology;2023-03-28